Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3565939)

Published in BMC Med on January 02, 2013

Authors

Tengyue Zhang1, Chong Pang, Ningdong Li, Elaine Zhou, Kanxing Zhao

Author Affiliations

1: Tianjin Medical University, 22 Qixiangtai Road, Tianjin, 300020, PR China.

Articles cited by this

Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48

Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99

A comprehensive review of genetic association studies. Genet Med (2002) 16.75

Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72

Molecular networks as sensors and drivers of common human diseases. Nature (2009) 6.14

Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22

Genetic associations in large versus small studies: an empirical assessment. Lancet (2003) 3.41

Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br J Ophthalmol (1974) 2.23

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A (1995) 1.99

Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care (1997) 1.58

MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation. Diabetes Care (2003) 1.56

The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin (2009) 1.30

Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care (2005) 1.27

Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes (2001) 1.27

Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology (2011) 1.23

Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci (2011) 1.22

Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas. J Ophthalmol (2010) 1.14

VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci (2008) 1.14

Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes (2006) 1.08

Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia (1998) 1.02

Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Ophthalmologica (2003) 1.01

Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia (1979) 1.01

PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol (1998) 0.99

Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int (2000) 0.99

Angiotensin-converting enzyme gene polymorphism is correlated to diabetic retinopathy: a meta-analysis. J Diabetes Complications (2008) 0.96

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol (1998) 0.94

Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract (2003) 0.94

An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy. Diabetes Res Clin Pract (2011) 0.93

The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet (2005) 0.90

Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy. Mol Vis (2007) 0.89

The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Mol Biol Rep (2012) 0.89

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost (1998) 0.88

Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice. Invest Ophthalmol Vis Sci (2000) 0.88

Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients. Dis Markers (2008) 0.88

Angiotensin-converting enzyme gene polymorphism is associated with proliferative diabetic retinopathy: a meta-analysis. Acta Diabetol (2009) 0.85

Association between the -634C/G polymorphisms of the vascular endothelial growth factor and retinopathy in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract (2010) 0.85

Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab (2009) 0.85

Genetic variation in promoter (4G/5G) of plasminogen activator inhibitor 1 gene in type 2 diabetes. Absence of relationship with microangiopathy. Diabetes Care (1998) 0.84

Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. Diabet Med (2004) 0.82

Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels. Endocr Res (2004) 0.82

[Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province]. Di Yi Jun Yi Da Xue Xue Bao (2004) 0.81

Articles by these authors

Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs. Am J Hum Genet (2009) 1.73

Changes of higher order aberration with various pupil sizes in the myopic eye. J Refract Surg (2003) 1.26

Two Chinese families with pulverulent congenital cataracts and deltaG91 CRYBA1 mutations. Mol Vis (2007) 1.23

A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1. Hum Genet (2006) 1.22

PRPF4 mutations cause autosomal dominant retinitis pigmentosa. Hum Mol Genet (2014) 1.22

Targeted sequencing of 179 genes associated with hereditary retinal dystrophies and 10 candidate genes identifies novel and known mutations in patients with various retinal diseases. Invest Ophthalmol Vis Sci (2013) 1.19

Five novel mutations of the FRMD7 gene in Chinese families with X-linked infantile nystagmus. Mol Vis (2008) 1.17

Novel deletion in the pre-mRNA splicing gene PRPF31 causes autosomal dominant retinitis pigmentosa in a large Chinese family. Am J Med Genet A (2003) 1.14

Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3. Arch Ophthalmol (2008) 1.08

Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci (2003) 1.01

Dark exposure extends the integration window for spike-timing-dependent plasticity. J Neurosci (2012) 0.98

Multifocal VEP difference between early- and late-onset strabismus amblyopia. Doc Ophthalmol (2005) 0.97

The ophthalmology surgical competency assessment rubric for strabismus surgery. J AAPOS (2012) 0.96

Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. Exp Eye Res (2007) 0.95

Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families. Mol Vis (2013) 0.94

An autosomal dominant progressive congenital zonular nuclear cataract linked to chromosome 20p12.2-p11.23. Mol Vis (2006) 0.90

Superior oblique tucking for treatment of superior oblique palsy. J Pediatr Ophthalmol Strabismus (2014) 0.86

Investigation of the gene mutations in two Chinese families with X-linked infantile nystagmus. Mol Vis (2011) 0.85

A locus for autosomal dominant accessory auricular anomaly maps to 14q11.2-q12. Hum Genet (2006) 0.84

Association of TP53 polymorphisms with primary open-angle glaucoma: a meta-analysis. Invest Ophthalmol Vis Sci (2012) 0.82

Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva. Cornea (2007) 0.81

Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis. PLoS One (2012) 0.81

Higher order aberrations and low contrast vision function in myopic eyes (-3.00 to -6.00 d) under mesopic conditions. J Refract Surg (2010) 0.78

[A novel rhodopsin E341ter mutation in patients with retinitis pigmentosa and corresponding clinical phenotype]. Zhonghua Yan Ke Za Zhi (2002) 0.78

Comparison of higher-order aberration and optical quality after Epi-LASIK and LASIK for myopia. Graefes Arch Clin Exp Ophthalmol (2010) 0.78

A novel approach to quantifying ciliary physiology: microfluidic mixing driven by a ciliated biological surface. Lab Chip (2013) 0.77

Providing prescheduled appointments as a strategy for improving follow-up compliance after community-based glaucoma screening: results from an urban underserved population. J Community Health (2015) 0.77

Inherited KIF21A and PAX6 gene mutations in a boy with congenital fibrosis of extraocular muscles and aniridia. BMC Med Genet (2013) 0.76

A novel homozygous BEST1 mutation correlates with complex ocular phenotypes. Ophthalmology (2013) 0.76

[Treatment of obstructive sleep apnea-hypopnea syndrome for children refractory asthma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.76

Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.76

The influences of dark rearing on the transmission characteristics of layer II/III pyramidal cells during the critical period. Brain Res (2012) 0.75

Identification of the forkhead transcriptional factor 2 (FOXL2) gene mutations in four Chinese families with blepharophimosis syndrome. Mol Vis (2013) 0.75

[Analysis of the causes of pediatric rhino-source diseases]. Zhonghua Er Ke Za Zhi (2009) 0.75

[Apply of RetCam Ⅱ and color Doppler imaging in persistent hyperplastic primary vitreous]. Zhonghua Yan Ke Za Zhi (2016) 0.75

[Hot topics in treatment of intermittent exotropia]. Zhonghua Yan Ke Za Zhi (2015) 0.75

[Analysis of intractable cough in 128 children]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2010) 0.75

Response to: Comparison of higher-order aberration and optical quality after Epi-LASIK and LASIK for myopia. Graefes Arch Clin Exp Ophthalmol (2010) 0.75

Diagnosis and surgical treatment of unilateral restrictive hypotropia and esotropia. J AAPOS (2011) 0.75